7Baggers
 Fort Baker Capital Management discloses 1% stake in Avadel Pharmaceuticals  Investing.com Australia Mon, 17 Nov 2025 16:16:25 GMT
 Janus Henderson discloses 4.87% stake in Avadel Pharmaceuticals By Investing.com  Investing.com Australia Mon, 17 Nov 2025 15:42:21 GMT
 Citadel Group discloses 2.12% stake in Avadel Pharmaceuticals By Investing.com  Investing.com Canada Mon, 17 Nov 2025 15:36:57 GMT
 Lundbeck takes the lead in acquisition race for Irish company  medwatch.com Mon, 17 Nov 2025 14:15:33 GMT
 Bank of America discloses 3.13% stake in Avadel Pharmaceuticals  Investing.com Mon, 17 Nov 2025 12:14:13 GMT
 Lundbeck battles Irish Alkermes over narcolepsy company  medwatch.com Mon, 17 Nov 2025 12:00:00 GMT
 Avadel Pharmaceuticals Receives Superior Proposal from Lundbeck  TipRanks Mon, 17 Nov 2025 11:36:23 GMT
 Alkermes (ALKS) Faces Potential Termination of Acquisition Agree  GuruFocus Mon, 17 Nov 2025 11:34:52 GMT
 Lundbeck values Avadel at up to $23 per share in takeover bid  Investing.com India Mon, 17 Nov 2025 11:21:43 GMT
 Morgan Stanley Capital Services discloses Avadel Pharmaceuticals trades By Investing.com  Investing.com South Africa Mon, 17 Nov 2025 10:31:28 GMT
 Avadel (AVDL) Gets 26% Boost on Takeover Bid  Yahoo Finance Sun, 16 Nov 2025 16:16:48 GMT
 Avadel (AVDL) Soars to 10-Year High on Brewing Bidding War  Insider Monkey Sat, 15 Nov 2025 12:13:07 GMT
 FIL Limited discloses 2.88% stake in Avadel Pharmaceuticals By Investing.com  Investing.com Nigeria Sat, 15 Nov 2025 00:24:30 GMT
 Goldman Sachs discloses dealings in Avadel Pharmaceuticals shares By Investing.com  Investing.com Nigeria Fri, 14 Nov 2025 23:41:50 GMT
 another bidding war as lundbeck swoops in on alkermes/avadel deal  Citeline News & Insights Fri, 14 Nov 2025 21:45:25 GMT
 To Wall Street, a new bidding war puts Alkermes in a tough spot  BioPharma Dive Fri, 14 Nov 2025 21:43:48 GMT
 A New Buyout Battle Is Brewing In Biotech; One Stock Is Up 20%  Investor's Business Daily Fri, 14 Nov 2025 21:04:00 GMT
 Avadel Pharmaceuticals Attracts Rival Bids In Buyout Showdown  Finimize Fri, 14 Nov 2025 19:13:34 GMT
 Avadel Faces Competing Bids From Lundbeck And Alkermes  Finimize Fri, 14 Nov 2025 18:52:59 GMT
 H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal  The Wall Street Journal Fri, 14 Nov 2025 16:03:00 GMT
 Citadel Group discloses 2.05% stake in Avadel Pharmaceuticals By Investing.com  Investing.com Nigeria Fri, 14 Nov 2025 15:22:20 GMT
 Lundbeck tries to upend Alkermes' takeout of sleep drug developer Avadel  FirstWord Pharma Fri, 14 Nov 2025 15:14:23 GMT
 Lundbeck makes unsolicited offer for Avadel Pharmaceuticals  The Pharma Letter Fri, 14 Nov 2025 14:38:21 GMT
 FIL Limited discloses 2.88% stake in Avadel Pharmaceuticals  Investing.com Fri, 14 Nov 2025 13:52:46 GMT
 Alkermes (ALKS) Evaluates Options Following Avadel Pharmaceutica  GuruFocus Fri, 14 Nov 2025 13:50:19 GMT
 lundbeck makes bid for avadel, trying to displace alkermes  pharmaphorum Fri, 14 Nov 2025 13:33:44 GMT
 form 8.3 - avadel pharmaceuticals plc  The Manila Times Fri, 14 Nov 2025 13:33:20 GMT
 alkermes responds to potential rival bid for avadel from lundbeck  Investing.com Fri, 14 Nov 2025 13:00:21 GMT
 alkermes responds to competing offer for avadel from lundbeck  StreetInsider Fri, 14 Nov 2025 12:47:31 GMT
 Alkermes Response to Avadel Announcement  PR Newswire Fri, 14 Nov 2025 12:45:00 GMT
 avadel stock soars after receiving $23 per share acquisition offer  Investing.com Fri, 14 Nov 2025 12:11:15 GMT
 Avadel climbs as Lundbeck outbids Alkermes in latest bidding war  Seeking Alpha Fri, 14 Nov 2025 11:57:52 GMT
 avadel climbs as lundbeck outbids alkermes (avdl:nasdaq)  Seeking Alpha Fri, 14 Nov 2025 11:57:52 GMT
 avadel considers lundbeck's proposal amid alkermes agreement (al  GuruFocus Fri, 14 Nov 2025 11:53:34 GMT
 Avadel Pharmaceuticals Receives Unsolicited Proposal from Lundbeck  TradingView Fri, 14 Nov 2025 11:15:00 GMT
 avadel receives unsolicited proposal from lundbeck  MarketScreener Fri, 14 Nov 2025 10:52:22 GMT
 Morgan Stanley discloses trading in Avadel Pharmaceuticals shares  Investing.com Fri, 14 Nov 2025 09:54:35 GMT
 citadel discloses 2.06% stake in avadel pharmaceuticals by investing.com  Investing.com Canada Fri, 14 Nov 2025 04:39:06 GMT
 goldman sachs reports trading activity in avadel pharmaceuticals by investing.com  Investing.com Nigeria Fri, 14 Nov 2025 03:28:20 GMT
 Bank of America discloses 3.1% stake in Avadel Pharmaceuticals By Investing.com  Investing.com Nigeria Fri, 14 Nov 2025 03:27:44 GMT
 FMR and FIL disclose 2.86% stake in Avadel Pharmaceuticals By Investing.com  Investing.com Nigeria Fri, 14 Nov 2025 03:07:38 GMT
 Goldman Sachs reports trading activity in Avadel Pharmaceuticals  Investing.com Thu, 13 Nov 2025 16:31:51 GMT
 FMR and FIL disclose 2.86% stake in Avadel Pharmaceuticals  Investing.com Thu, 13 Nov 2025 16:08:24 GMT
 Citadel discloses 2.06% stake in Avadel Pharmaceuticals  Investing.com Thu, 13 Nov 2025 15:09:40 GMT
 Bank of America discloses 3.1% stake in Avadel Pharmaceuticals  Investing.com Thu, 13 Nov 2025 13:33:03 GMT
 Alkermes, Avadel Pharmaceuticals file US merger paperwork  MLex Thu, 13 Nov 2025 13:04:00 GMT
 Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares  Investing.com Thu, 13 Nov 2025 10:47:12 GMT
 avadel pharmaceuticals stock hits 52-week high at 19.06 usd by investing.com  Investing.com Nigeria Thu, 13 Nov 2025 05:25:26 GMT
 Avadel Pharmaceuticals stock hits 52-week high at 19.06 USD  Investing.com Wed, 12 Nov 2025 19:23:23 GMT
 citadel group discloses 2.06% stake in avadel pharmaceuticals  Investing.com Wed, 12 Nov 2025 15:30:09 GMT
 bank of america discloses 3.1% stake in avadel pharmaceuticals  Investing.com Wed, 12 Nov 2025 11:08:52 GMT
 morgan stanley capital services discloses dealings in avadel shares by investing.com  Investing.com Australia Wed, 12 Nov 2025 10:39:05 GMT
 morgan stanley discloses trading activity in avadel pharmaceuticals  Investing.com Wed, 12 Nov 2025 10:31:14 GMT
 morgan stanley discloses avadel pharmaceuticals trading activity by investing.com  Investing.com Nigeria Wed, 12 Nov 2025 08:28:39 GMT
 bank of america discloses 3% stake in avadel pharmaceuticals by investing.com  Investing.com Nigeria Wed, 12 Nov 2025 08:23:06 GMT
 geode capital discloses 2.24% stake in avadel pharmaceuticals by investing.com  Investing.com Nigeria Wed, 12 Nov 2025 08:21:00 GMT
 goldman sachs & co. - form 38.5b - avadel pharmaceuticals plc  Research Tree Tue, 11 Nov 2025 15:03:48 GMT
 Geode Capital discloses 2.24% stake in Avadel Pharmaceuticals  Investing.com Tue, 11 Nov 2025 13:55:31 GMT
 bank of america discloses 3% stake in avadel pharmaceuticals  Investing.com Tue, 11 Nov 2025 13:52:42 GMT
 form 8.3 - the vanguard group, inc.: avadel pharmaceuticals plc  TradingView Tue, 11 Nov 2025 13:51:05 GMT
 Goldman Sachs discloses trading activity in Avadel Pharmaceuticals  Investing.com Tue, 11 Nov 2025 11:56:58 GMT
 Morgan Stanley discloses Avadel Pharmaceuticals trading activity  Investing.com Tue, 11 Nov 2025 09:57:33 GMT
 bank of america discloses 3.08% stake in avadel pharmaceuticals by investing.com  Investing.com Nigeria Tue, 11 Nov 2025 06:57:13 GMT
 goldman sachs (ept) - form 38.5b - avadel pharmaceuticals plc  Research Tree Tue, 11 Nov 2025 03:25:22 GMT
 morgan stanley&collc - rule 38.5_a - avadel pharmaceuticals plc  Research Tree Tue, 11 Nov 2025 03:11:25 GMT
 citadel group discloses 2.05% stake in avadel pharmaceuticals  Investing.com Mon, 10 Nov 2025 15:12:41 GMT
 tudor investment corporation discloses 3.06% stake in avadel by investing.com  Investing.com India Mon, 10 Nov 2025 14:10:04 GMT
 form 8.3 - avadel pharmaceuticals plc  The Manila Times Mon, 10 Nov 2025 13:47:52 GMT
 Bank of America discloses 3% stake in Avadel Pharmaceuticals  Investing.com Mon, 10 Nov 2025 13:10:42 GMT
 bank of america discloses 3.08% stake in avadel pharmaceuticals  Investing.com India Mon, 10 Nov 2025 12:28:47 GMT

Avadel Pharmaceuticals plc
(NASDAQ:AVDL) 

AVDL stock logo

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. The company's lead product candidate is FT218, a formulation of sodium oxybate which is in a Phase 3 clinical trial for the treatment excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy. T...

Founded: 1990
Full Time Employees: 50
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends